Tobi podhaler 28 MG inhale cap UD 56S
Ended Awarded
- Contract number
- SPE2DB25FY9PQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,719
Award facts
- Contract value 100% obligated
- $41,719.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,719.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tobi Podhaler 28 mg inhalable capsules (56-unit dose packages) on August 19, 2025, with completion targeted for August 20, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric and adult cystic fibrosis treatment, positioning the pharmaceutical distributor to supply critical respiratory therapy medications to military and federal healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle enabling the company to deliver a broad portfolio of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an established track record of competitively awarded contracts with the DLA covering specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FY9PQ?
SPE2DB25FY9PQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FY9PQ worth?
The government has obligated $41,719 on SPE2DB25FY9PQ.
Is contract SPE2DB25FY9PQ an order under another contract?
Yes. SPE2DB25FY9PQ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9PQ competed?
The extent of competition for SPE2DB25FY9PQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award